Ibandronate ( DrugBank: Ibandronate )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
49	Systemic lupus erythematosus	1

46. Malignant rheumatoid arthritis

---

Clinical trials : 4,325 /  Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01287533 (ClinicalTrials.gov)	April 2010	30/1/2011	Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids	Efficacy of Monthly Ibandronate in Women With Rheumatoid Arthritis and Reduced Bone Mineral Density Receiving Long-term Glucocorticoids	Rheumatoid Arthritis;Osteoporosis;Osteopenia	Drug: Ibandronate;Drug: Placebo	Yeong-Wook Song	NULL	Completed	18 Years	75 Years	Female	167	Phase 4	Korea, Republic of

49. Systemic lupus erythematosus

---

Clinical trials : 946 /  Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00668330 (ClinicalTrials.gov)	April 2007	25/4/2008	Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus	Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus-Prevalence,Risk Factors and Treatment	Systemic Lupus Erythematosus	Drug: Ibandronate+alfacalcidol+calcium;Drug: placebo ibandronate+alfacalcidol+calcium	Chinese University of Hong Kong	NULL	Completed	18 Years	80 Years	Female	40	Phase 4	China